Stantec Kept at Buy at Stifel GMP Following Q4 Results; Price Target Raised to C$144.00

MT Newswires Live
2025/02/26

Stifel GMP on Wednesday reiterated its buy rating on the shares of Stantec (STN.TO, STN) while raising its price target to C$144.00 from US$135.00 following fourth-quarter results from the engineering and design company.

"One of the simple investment philosophies we have for the engineering firms in our coverage is to own the stock that has the longest passage of time since a sizable acquisition. Acquisitions for engineering firms tend to create positive share price reactions and relative outperformance. Of the three engineering firms in our coverage, Stantec appears to be next up to execute M&A since WSP acquired Power in the fall and AtkinsRealis acquired David Evans in February 2025. On top of the M&A setup, we continue to like the fundamentals (7.0%+ organic growth and margin expansion), in combination with a reasonable 2026E P/E of 20.8x (peer group 17.0x) given M&A prospects. We have increased our target price to $144/sh (prior: $135/sh), while maintaining our BUY rating," analyst Ian Gillies wrote.

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)

Price: 123.05, Change: +3.12, Percent Change: +2.60

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10